Science Explorer Interactive view Map
Company · Kurume · Japan

BrightPath Biotherapeutics (Japan)

brightpathbio.com/englishROR OpenAlex
Research works
12
fractional, all time
Citations
61
5.0 per fractional work
Top-10% rate
2.3%
record average 16.5%
Open access
57%
world 28%

Not ranked overall: BrightPath Biotherapeutics (Japan) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Which research topics does BrightPath Biotherapeutics (Japan) publish most on?

By volume in 2022–2025: CAR-T cell therapy research, Adenosine and Purinergic Signaling, Immune Cell Function and Interaction and Immunotherapy and Immune Responses.

CAR-T cell therapy resea…2CAR-T cell therapy research: 2 fractional worksAdenosine and Purinergic Signaling: 1 fractional worksImmune Cell Function and Interaction: 1 fractional worksImmunotherapy and Immune Responses: 0 fractional worksCancer Immunotherapy and Biomarkers: 0 fractional worksMonoclonal and Polyclonal Antibodies Research: 0 fractional worksGalectins and Cancer Biology: 0 fractional worksCancer Research and Treatments: 0 fractional worksvaccines and immunoinformatics approaches: 0 fractional worksClick Chemistry and Applications: 0 fractional works
OncologyPhysiologyImmunologyRadiology, Nuclear Medicine and Imaging3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 CAR-T cell therapy research Oncology 2 works
  2. 2 Adenosine and Purinergic Signaling Physiology 1 works
  3. 3 Immune Cell Function and Interaction Immunology 1 works
  4. 4 Immunotherapy and Immune Responses Immunology 0 works
  5. 5 Cancer Immunotherapy and Biomarkers Oncology 0 works
  6. 6 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  7. 7 Galectins and Cancer Biology Immunology 0 works
  8. 8 Cancer Research and Treatments Biotechnology 0 works
  9. 9 vaccines and immunoinformatics approaches Molecular Biology 0 works
  10. 10 Click Chemistry and Applications Organic Chemistry 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available56.9%not open43.1%

World: 28% of research is openly available.

with international co-authors2.9%domestic only97.1%

World: 19% is written across borders.

How has BrightPath Biotherapeutics (Japan)'s research output changed?

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Kurume

All research institutions in Kurume

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.